Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea flag South Korea · Delayed Price · Currency is KRW
91,000
-700 (-0.76%)
Mar 27, 2026, 3:19 PM KST

KRX:185750 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,201,6571,092,2961,178,9821,665,7131,001,8201,312,265
Market Cap Growth
11.22%-7.35%-29.22%66.27%-23.66%-49.00%
Enterprise Value
1,225,5141,169,9041,062,3001,643,5061,090,1501,317,515
Last Close Price
91200.0082900.0088479.53122485.7472561.9992402.74
PE Ratio
15.6014.0910.817.8412.3830.72
Forward PE
16.8014.4714.4718.8411.9814.96
PS Ratio
0.710.650.741.000.670.98
PB Ratio
1.191.091.322.041.612.32
P/TBV Ratio
1.321.201.442.181.682.41
P/FCF Ratio
--45.676.0243.87-
P/OCF Ratio
17.8416.2218.345.2414.79101.70
PEG Ratio
-8.178.178.178.178.17
EV/Sales Ratio
0.720.690.670.980.730.98
EV/EBITDA Ratio
9.789.337.635.807.6010.78
EV/EBIT Ratio
15.2114.5210.686.679.9213.90
EV/FCF Ratio
-16.66-41.155.9347.74-
Debt / Equity Ratio
0.370.370.210.270.380.42
Debt / EBITDA Ratio
2.932.931.350.771.641.94
Debt / FCF Ratio
--7.290.7910.32-
Net Debt / Equity Ratio
0.020.02-0.13-0.180.130.09
Net Debt / EBITDA Ratio
0.170.17-0.82-0.510.560.41
Net Debt / FCF Ratio
-0.29-0.29-4.42-0.523.50-1.41
Asset Turnover
1.041.041.111.321.371.35
Inventory Turnover
2.982.983.433.793.824.13
Quick Ratio
1.251.251.631.321.161.30
Current Ratio
2.122.122.611.851.912.08
Return on Equity (ROE)
8.18%8.18%13.02%29.73%13.47%7.58%
Return on Assets (ROA)
3.09%3.09%4.35%12.20%6.33%5.94%
Return on Invested Capital (ROIC)
7.50%8.49%13.69%31.79%13.74%8.73%
Return on Capital Employed (ROCE)
6.30%6.30%9.10%27.70%14.60%13.00%
Earnings Yield
6.45%7.10%9.25%12.76%8.08%3.26%
FCF Yield
-6.12%-6.73%2.19%16.63%2.28%-2.69%
Payout Ratio
17.84%17.84%12.22%5.46%13.88%25.30%
Buyback Yield / Dilution
-0.50%-0.50%5.20%-3.79%1.77%0.73%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.